Načítá se...

Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action

Insulin analogs were developed to improve diabetes therapy. However, certain modifications introduced into the insulin molecule were shown to enhance their affinity to the insulin-like growth factor-1 receptor (IGF1R). Most tumors, including endometrial cancers, express high levels of IGF1R. The pre...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Daniel Aizen, Metsada Pasmanik-Chor, Rive Sarfstein, Zvi Laron, Ilan Bruchim, Haim Werner
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2018-03-01
Edice:Frontiers in Endocrinology
Témata:
On-line přístup:http://journal.frontiersin.org/article/10.3389/fendo.2018.00105/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!